Cargando…

Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease

Castleman disease is a rare lymphoproliferative disorder presenting with localized or disseminated lymphadenopathy and systemic symptoms. It can be categorized clinically as unicentric or multicentric, histopathologically as hyaline vascular, plasma cell, or mixed variant, and etiologically, conside...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moutinho, Adelaide, Cunha, Rita Gamboa, Jamal, Sheila Koch, Lisboa, Marta Meleiro, Tavares, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062188/ https://www.ncbi.nlm.nih.gov/pubmed/33936820 http://dx.doi.org/10.1155/2021/6620666

Ejemplares similares

Castleman Disease Presenting with Jaundice: A Case with the Multicentric Hyaline Vascular Variant
por: Park, Jun bean, et al.
Publicado: (2007)

Perigastric Hyaline-Vascular Variant Castleman's Disease
por: Jin, Yu Ming, et al.
Publicado: (2021)

Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report
por: Basnayake, B. M. D. B., et al.
Publicado: (2017)

Hyaline vascular- type Castleman's disease in the hilum of liver: a case report
por: Karami, Hossein, et al.
Publicado: (2010)

Multicentric Castleman Disease: The Hyaline Vascular Type Without HIV Association in a Young Male With Cutaneous Manifestation and Renal Impairment
por: Khan, Abed H, et al.
Publicado: (2022)

A multicentric, hyaline vascular variant of Castleman's disease associated with B cell lymphoma: a case report
por: Erkurt, Mehmet Ali, et al.
Publicado: (2009)

Hyaline Vascular-Type Castleman Disease Presenting as an Esophageal Submucosal Tumor: Case Report
por: Kim, Ki Nam, et al.
Publicado: (2006)

Hyaline Vascular Type of Castleman Disease: Diagnostic Pitfalls on Cytology and Its Clinical Relevance
por: Singh, Neha, et al.
Publicado: (2021)

Morphologic variant of follicular lymphoma reminiscent of hyaline-vascular Castleman disease
por: Koh, Jiwon, et al.
Publicado: (2020)

Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases
por: Cen, Jiemei, et al.
Publicado: (2023)

Primary hyaline vascular Castleman disease of the kidney: case report and literature review
por: Li, Yunzhu, et al.
Publicado: (2019)

Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report
por: Li, Ping, et al.
Publicado: (2019)

Clinical and Pathological Characteristics of Hyaline-Vascular Type Unicentric Castleman Disease: A 20-Year Retrospective Analysis
por: Nishimura, Midori Filiz, et al.
Publicado: (2021)

Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report
por: Ge, Yijun, et al.
Publicado: (2018)

Candidate biomarkers for idiopathic multicentric Castleman disease
por: Sumiyoshi, Remi, et al.
Publicado: (2022)

Alveolar Hemorrhage in Idiopathic Multicentric Castleman’s Disease
por: Huang, Lingtong, et al.
Publicado: (2023)

Hyaline-vascular type unicentric Castleman disease with dysplastic follicular dendritic cell proliferative lesions: a case report
por: Horikawa, Daisuke, et al.
Publicado: (2023)

Hyaline Vascular Castleman Disease Involving Renal Parenchyma and a Lymph Node: A Case Report
por: Kwon, Ji Hyun, et al.
Publicado: (2012)

Intra-abdominal localized hyaline-vascular Castleman disease: imaging characteristics and management of a rare condition
por: Vassos, Nikolaos, et al.
Publicado: (2016)

Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like features
por: Togitani, Kazuto, et al.
Publicado: (2021)

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
por: Pierson, Sheila K., et al.
Publicado: (2022)

Multicentric Castleman's Disease, Associated with Idiopathic Thrombocytopenic Purpura
por: Sood, Ruchi, et al.
Publicado: (2013)

Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease
por: Nishikori, Asami, et al.
Publicado: (2022)

Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report
por: Kosmidis, Christoforos S., et al.
Publicado: (2022)

The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease
por: Horna, Pedro, et al.
Publicado: (2022)

Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes
por: Pierson, Sheila K., et al.
Publicado: (2023)

Follicular dendritic cell sarcoma aggravated by hyaline-vascular Castleman's disease in association with paraneoplastic pemphigus: study of the tumor and successful treatment()()
por: Wang, Jing, et al.
Publicado: (2019)

A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome
por: Ük, Ece, et al.
Publicado: (2022)

Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
por: Otoshi, Ryota, et al.
Publicado: (2023)

A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy
por: Falchi, Lorenzo, et al.
Publicado: (2007)

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
por: Aita, Tetsuro, et al.
Publicado: (2020)

A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
por: Rolfes, Leoni, et al.
Publicado: (2019)

Cutaneous plasmacytosis: A rare initial presentation of idiopathic multicentric Castleman's disease
por: Yamamoto, Yu, et al.
Publicado: (2021)

Idiopathic Multicentric Castleman Disease Presenting With Hypertensive Choroidopathy: A Case Report
por: Mimoto, Tamami, et al.
Publicado: (2023)

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease
por: van Rhee, Frits, et al.
Publicado: (2022)

Different Types of Skin Lesions in Multicentric Castleman Disease
por: Nakamura, Yoshihiro, et al.
Publicado: (2022)

Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine
por: Hoffmann, Christian, et al.
Publicado: (2022)

The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman’s disease
por: Min, Gi-June, et al.
Publicado: (2021)

Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report
por: Lang, Evan, et al.
Publicado: (2022)

Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
por: Nishimura, Yoshito, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hsf81ru30braje73d50ql38h53